Form Icon
Online Registration
Calendar Icon
Request an appointment
Person Icon
For Patients
Doctor Icon
For Physicians
Phone Icon

Firas M. Rahhal, M.D.

“It is my mission to provide the best medical and surgical treatment to all of my patients while continually working to find state-of-the-art treatment options through a continued commitment to clinical research.”


Dr. Firas Rahhal is a leading board-certified retina specialist focusing on the treatment of vitreoretinal diseases, such as diabetic retinopathy, age-related macular degeneration, retinal detachments, and Uveitis. Dr. Rahhal is an accomplished clinician and researcher and an internationally recognized leader in retina surgery. Dr. Rahhal has been an investigator in more than 100 national and international clinical trials, which have led to new and novel therapies for vitreoretinal diseases.

Dr. Rahhal serves as Associate Clinical Professor of Ophthalmology at the UCLA School of Medicine – Jules Stein Eye Institute. He has published dozens of scientific papers in reputable peer-reviewed journals. He is also an oft saught speaker at international scientific meetings. Among numerous other awards, Dr. Rahhal has been consistently named “Top Doctor” by his physician peers in the Los Angeles Magazine annual review.

  • College
    Bachelor of Arts in Biochemistry from the University of Pennsylvania, Philadelphia, Pennsylvania
  • Medical School
    Doctor of Medicine from the University of Connecticut School of Medicine, Farmington, Connecticut
  • Internship
    Internal Medicine Internship at the University of California, Los Angeles, Los Angeles, California
  • Residency
    Ophthalmology Residency at Cornell University Medical College/ The New York Hospital
  • Fellowship
    Vitreo-Retinal Diseases and Surgery, Uveitis, University of California, San Diego, California
  • American Society of Retina Specialists
  • The Retina Society
  • American Academy of Ophthalmology
  • ASRS Practice Management Committee
  • Novartis RAD001A2203: A randomized, double-masked, parallel group study to assess the efficacy of oral Everolimus 5 mg once daily, either alone or added to Lucentis, in patients with neovascular age-related macular degeneration
  • Vitreo Retino Technologies- PVD-301 “A Phase 3 Safety and Efficacy Study of Vitreosolve ® for Ophthalmic Intravitreal Injection for Inducing Posterior Vitreous Detachment in Retinopathy Subjects”
  • CATT: Avastin vs. Lucentis The Comparison of Age-Related Macular Degeneration Ireatments Trials (CATT) is a multi-centered randomized clinical trial to assess the relative safety and efficacy of two treatments for subfoveal neovascular Age-Related Macular Degeneration (AMD)
  • Dr. Jason Slakter TAPER: “Triple Therapy in AMD with PDT to Extend the Time to Retreatment (TAPER)”- A Multicenter, Randomized, Single-Masked Comparison ofLucentis™ Monotherapywith Triple Therapy of Reduced Fluence Visudyne-Lucentis-Dexamethasone (V-L-D) in Patients with CNV Secondary to AMD as Second Line Therapy After Lucentis Monotherapy
  • “Verteporfin in age related macular degeneration (VAM)”
    QLT/Ciba-Geigy, 1999-2000
  • “Green fluorescent protein as a marker for transplantation of retinal pigment epithelium”
    The Research Division of PREVENT BLINDNESS AMERICA Fight for Sight grant# GA97046

On-Time Doctor Award 
Vitals On-Time + Promptness Award recognizes doctors with consistent high ratings for timeliness of appointments. The honor is granted based on a physician’s overall and promptness scores. (2016)

Patients’ Choice Award
Patients’ Choice recognition reflects the difference a particular physician has made in the lives of his/her patients. The honor is bestowed to physicians who have received near perfect scores, as voted by patients. (2016, 2014)

Compassionate Doctor Recognition 
Compassionate Doctor certification is granted to physicians who treat their patients with the utmost kindness. The honor is granted based on a physician’s overall and bedside manner scores. (2016, 2014)

WARNING: Internet Explorer does not support modern web standards. This site may not function correctly on this browser and is best viewed on Chrome, Firefox or Edge browsers. Learn More.